Comparison of hepatocellular carcinoma in E astern versus W estern populations

SP Choo, WL Tan, BKP Goh, WM Tai, AX Zhu - Cancer, 2016 - Wiley Online Library
Cancer, 2016Wiley Online Library
Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent
in many Asian countries and is the second most common cause of cancer‐related mortality
worldwide. Significant differences exist between Eastern and Western populations on many
key aspects of HCC, contributing to the potential different treatment outcomes and
challenges of clinical trial design and data interpretation. In this review, the authors compare
HCC in Asia versus the West and highlight 1) differences in terms of epidemiology and …
Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent in many Asian countries and is the second most common cause of cancer‐related mortality worldwide. Significant differences exist between Eastern and Western populations on many key aspects of HCC, contributing to the potential different treatment outcomes and challenges of clinical trial design and data interpretation. In this review, the authors compare HCC in Asia versus the West and highlight 1) differences in terms of epidemiology and trends and their correlation with etiology, 2) differences in genetics and how they relate to underlying etiology, 3) differences in treatment approaches based on existing guidelines and consensus statements, and 4) differences in clinical outcomes for Asian versus non‐Asian patients with HCC in clinical trials and the implications for future clinical trial design. Cancer 2016;122:3430–3446. © 2016 American Cancer Society
Wiley Online Library